Background and objective: Acinetobacter baumannii ( A. baumannii ) is a common nosocomial pathogen, which developed multi-drug-resistance to different classes of antibiotics including carbapenems. This study examined ten common carbapenemase genes among 32 carbapenem-resistant A. baumannii clinical isolates recovered from Taif, Saudi Arabia. Methods: Isolates were phenotypically identified to the genus level by Vitek ® 2 and API 20NE ® . The species level was confirmed by the amplification of bla OXA-51 . The susceptibility for 21 different antibiotics was performed by Vitek 2 and modified Kirby-Bauer method. Isolates were genetically screened for 10 carbapenemases. Phylogenetic relatedness between isolates was determined by ERIC-PCR. Results: Genotypically identified A. baumannii represented 100% of the total phenotypically identified Acinetobacter spp. All the carbapenem-resistant isolates were sensitive to polymyxin B and colistin. Among the other antibiotics, ampicillin/sulbactam and tigecycline were the most effective agents. 90.8% of the isolates were resistant to all ten investigated β–lactams. bla OXA-51, bla IPM , bla NDM and bla OXA-23 were detected in 100%, 87.5%, 62.5% and 59.4% of isolates, respectively. Also, bla VIM and bla OXA-40 were less prevalent and were detected in 9.3% and 3.1% of the isolates, respectively. In addition, bla KPC , bla OXA-48 , bla OXA-58 , bla OXA-181 were not detected in any isolate. The A. baumannii isolates were categorised into ten genotypes on the basis of the detected carbapenemase genes and ERIC-PCR revealed a remarkable clonal diversity among these isolates. Conclusion: Class A and class D carbapenemase genes were the most commonly detected among carbapenem resistant A. baumannii (CRAB) clinical isolates. Keywords: A. baumannii , bla OXA-51 , carbapenemases, carbapenems, ERIC-PCR
No takes yet. Share an insight, caveat, or question.
El‐Badawy et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: